Crossref
Bempedoic acid for primary hypercholesterolaemia
Prescriber · 2021-01 · 32 (1) · 29-31
DOI: 10.1002/psb.1888 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prescriber, online erschienen am 21.01.2021. Verfasst von Steve Chaplin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Bempedoic acid (Nilemdo) is a new lipid‐lowering therapy for the treatment of primary hypercholesterolaemia and mixed dyslipidaemia. This article summarises its mechanism of action, clinical trial efficacy and side‐effects.
Zitieren
APA
Chaplin, S. (2021). Bempedoic acid for primary hypercholesterolaemia. Prescriber, 32(1), 29-31. https://doi.org/10.1002/psb.1888
Vancouver
Chaplin S. Bempedoic acid for primary hypercholesterolaemia. Prescriber. 2021;32(1):29-31. doi:10.1002/psb.1888
BibTeX
@article{Chaplin2021,
author = {Chaplin, Steve},
title = {Bempedoic acid for primary hypercholesterolaemia},
journal = {Prescriber},
year = {2021},
volume = {32},
number = {1},
pages = {29--31},
doi = {10.1002/psb.1888}
}
EUVIMED